Walgreens Boots Alliance, Inc. is a prominent player in the pharmaceutical distribution sector, with a strong emphasis on retail operations. The company generates the majority of its revenue from the sale of prescription and over-the-counter drugs, as well as beauty and cosmetic products. Its primary market is the United States, contributing 90.9% of its retail sales.

Walgreens operates 13,532 points of sale, including 8,706 locations across the U.S., Puerto Rico, and the U.S. Virgin Islands, alongside its online sales platform. In addition to retail, the company is involved in wholesale distribution, accounting for 8.1% of its sales, while the healthcare sector contributes the remaining 4.7%. Geographically, the majority of the company's net sales come from the United States at 84%, followed by Germany at 8.1%, the United Kingdom at 6.5%, and other regions at 1.4%.

The competitive landscape of the pharmaceutical industry has led UBS to maintain a neutral rating on Walgreens Boots Alliance, reflecting a cautious outlook. However, the company's strong retail operations and diverse product offerings position it as a key player in the market.